1145-01-3 | 3,5-Diphenylpyrazole

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$10.00	$7.00
10g	98%	in stock	$12.00	$9.00
25g	98%	in stock	$28.00	$19.00
100g	98%	in stock	$108.00	$76.00

Description

• Catalog Number: AA18707
• Chemical Name: 3,5-Diphenylpyrazole
• CAS Number: 1145-01-3
• Molecular Formula: C15H12N2
• Molecular Weight: 220.2692
• MDL Number: MFCD00039675
• SMILES: c1ccc(cc1)c1[nH]nc(c1)c1ccccc1
• NSC Number: 126937

Computed Properties

• Complexity: 229
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 17
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 2
• XLogP3: 3.5

Literature

• Cyclometalated iridium(III) complexes containing hydroxide/chloride ligands: isolation of heterobridged dinuclear iridium(III) compounds containing μ-OH and μ-pyrazole ligands.

  Inorganic chemistry 20121015

• 3,5-Bis(2,4-dinitro-phen-yl)-4-nitro-1H-pyrazole acetone monosolvate.

  Acta crystallographica. Section E, Structure reports online 20120201

• Organolanthanoid-halide synthons--a new general route to monofunctionalized lanthanoid(II) compounds?

  Chemical communications (Cambridge, England) 20100728

• Carbon-yl[tris-(3,5-diphenyl-pyrazol-1-yl-κN)methane]copper(I) hexa-fluorido-phosphate-dichloro-methane-diethyl ether (4/3/1).

  Acta crystallographica. Section E, Structure reports online 20091101

• Self-assembly in helical columnar mesophases and luminescence of chiral 1H-pyrazoles.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20090914

• Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins.

  Journal of medicinal chemistry 20080814

• Dichloridobis(3,5-dimethyl-1H-pyrazol-4-amine-κN)cobalt(II).

  Acta crystallographica. Section E, Structure reports online 20080801

• Alkali-metal pyrazolate complexes with unusual pyrazolate coordination modes and pseudocubane motifs.

  Chemistry, an Asian journal 20070402

• Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors.

  Journal of medicinal chemistry 20070208

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• B-N bond cleavage by cobalt(II) in acetato(3,5-diphenylpyrazole)[tris(3,5-diphenylpyrazolyl)borato]cobalt(II).

  Acta crystallographica. Section C, Crystal structure communications 20050601

• Dynamic NMR study of the mechanisms of double, triple, and quadruple proton and deuteron transfer in cyclic hydrogen bonded solids of pyrazole derivatives.

  Journal of the American Chemical Society 20040922

• Heavy alkaline earth metal pyrazolates: synthetic pathways, structural trends, and comparison with divalent lanthanoids.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20040705

• Reactions of lanthanoid metals with 3,5-diphenylpyrazole at elevated temperatures: synthesis and structures of both homoleptic, [Ln3(Ph2pz)9] (Ln = La, Nd), [Ln2(Ph2pz)6] (Ln = Er, Lu), and heteroleptic, [Ln(Ph2pz)3(Ph2pzH)2] (Ln = La, Nd, Gd, Tb, Er or Yb), pyrazolate complexes.

  Dalton transactions (Cambridge, England : 2003) 20040421

• Flash vacuum pyrolysis over solid catalysts. 2. pyrazoles over hydrotalcites.

  The Journal of organic chemistry 20021115

• Flash vacuum pyrolysis over solid catalysts. 1. Pyrazoles over zeolites.

  The Journal of organic chemistry 20010504